scispace - formally typeset
Journal ArticleDOI

Pulmonary arterial hypertension (PAH) from autopsy study: T-cells, B-cells and mastocytes detection as morphological evidence of immunologically mediated pathogenesis.

TLDR
In this article, the inflammatory infiltrate seems to be implicated as a main factor in the pathogenesis of pulmonary arterial hypertension (PAH) and lymphocytic populations associated to lesions with reactive neo-angiogenesis.
Abstract
Background Pulmonary arterial hypertension (PAH) is characterized by severe vascular remodelling, resulting in increased pulmonary vascular resistance with cardiac hypertrophy and heart failure. However, the diagnosis of PAH is often inaccurate. Many cases of PAH are incorrectly diagnosed or missed, and they are often associated with death. The aim of this study was to verify the morphological and histological criteria of fatal cases of PAH and evaluate the lymphocytic populations associated to lesions with reactive neo-angiogenesis. Methods Pulmonary lung sections from 10 cases of sudden unexpected death (SUD) in the absence of previously diagnosed diseases and in an apparent state of well-being, with final histological post autopsy diagnosis of PAH were collected. The pathological findings were compared using ten controls from non-pathological lung from deaths from other causes. The autopsies included 4 males (40%) and 6 females (60%) with an average age of 52.1 ± 10.1 years. Sections stained with hematoxylin and eosin (HE p  Conclusions The inflammatory infiltrate should be included for a correct diagnosis of PAH besides the vascular remodelling. The inflammatory infiltrate seems to be implicated as a main factor in the pathogenesis. This finding is important to rule out secondary pulmonary hypertension, to identify SUDs of unknown causes and to add new elements to the literature that can explain the immunologically related pathogenesis of PAH.

read more

Citations
More filters
Journal ArticleDOI

Iron Metabolism and Idiopathic Pulmonary Arterial Hypertension: New Insights from Bioinformatic Analysis

TL;DR: Zhang et al. as discussed by the authors explored the regulatory mechanisms of iron metabolism in IPH by bioinformatic analysis and identified 7 key genes (BCL2, GCLM, MSMO1, SLC7A11, SRXN1, TSPAN5, and TXNRD1).
Journal ArticleDOI

Identification of ferroptosis-associated genes exhibiting altered expression in pulmonary arterial hypertension.

TL;DR: In this article, the authors used gene expression profiles from 15 patients with pulmonary arterial hypertension (PAH) and 11 normal controls to identify differentially expressed genes (DEGs) associated with PAH-associated ferroptosis.
Journal ArticleDOI

B lymphocytes subpopulations are associated with cardiac remodeling in elderly patients with advanced chronic kidney disease

TL;DR: Wang et al. as discussed by the authors investigated the potential roles of B lymphocyte populations with cardiac remodeling in elderly patients with advanced chronic kidney disease (CKD) and found that the prevalence of hypertension was more common in CKD patients than in the control subjects (P < 0.05).
Journal ArticleDOI

Identification of immune-related hub genes and analysis of infiltrated immune cells of idiopathic pulmonary artery hypertension

TL;DR: In this article , the authors used Weighted gene correlation network analysis (WGCNA) to construct the co-expression gene networks of IPAH and found that the gray module was the most relevant module and genes in the module enriched in terms like inflammatory and immune responses.
Journal ArticleDOI

Innate immune response in hypertension.

TL;DR: The critical evidence of the role of innate immune cells in hypertension came from the results of clinical trials involving therapies blocking inflammatory cytokines and Toll-like receptor expression.
References
More filters
Journal ArticleDOI

Haemodynamic definitions and updated clinical classification of pulmonary hypertension.

TL;DR: The 6th WSPH Task Force proposed to include pulmonary vascular resistance ≥3 Wood Units in the definition of all forms of pre-capillary PH associated with mPAP >20 mmHg, and included in group 1 of a subgroup “pulmonary arterial hypertension (PAH) long-term responders to calcium channel blockers”.
Journal ArticleDOI

Definitions and diagnosis of pulmonary hypertension.

TL;DR: Early diagnosis of PAH remains difficult, and screening programs in asymptomatic patients are feasible only in high-risk populations, particularly in patients with systemic sclerosis, for whom recent data suggest that a combination of clinical assessment and pulmonary function testing has a higher predictive value than echocardiography alone.
Journal ArticleDOI

An epidemiological study of pulmonary arterial hypertension

TL;DR: All hospitalisations for pulmonary arterial hypertension (PAH) in the Scottish population were examined to determine the epidemiological features of PAH, and hospitalisation data from the Scottish Morbidity Record scheme gave higher prevalences of pulmonary arterIAL hypertension thanData from the expert centres (Scotland and France).
Journal ArticleDOI

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.

TL;DR: It is shown how genetic and metabolic abnormalities are inextricably linked to dysregulated immunity and adverse remodeling in the pulmonary arteries.
Related Papers (5)